KN

Kazuhiko Nonomura

AS Askat: 4 patents #4 of 21Top 20%
NA Novartis Ag: 3 patents #1,476 of 5,128Top 30%
RP Raqualia Pharma: 3 patents #18 of 69Top 30%
Overall (All Time): #497,404 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
11840530 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Shinichi Koizumi, Takako Okumura 2023-12-12
10975070 Ghrelin receptor agonist for treatment of cachexia Kaoru Shimada, Masaki Sudo, Masaomi Tajimi, Nobuyuki Takahashi 2021-04-13
10947235 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Shinichi Koizumi, Takako Okumura 2021-03-16
10611761 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Shinichi Koizumi, Takako Okumura 2020-04-07
9867811 Method of treating atherosclerosis in high triglyceride subjects Yoshie ARAI, Margaret Elizabeth Brousseau, Jessie Gu, Tomoko Hayashi, Hironobu Mitani +2 more 2018-01-16
9688674 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Shinichi Koizumi, Takako Okumura 2017-06-27
9457084 Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseases Kiyoshi Kanazawa, Takako Okumura, Shinichi Koizumi 2016-10-04
8921391 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Shinichi Koizumi, Takako Okumura 2014-12-30
8431589 2,4-diaminopyrimidine derivatives Rolf Baenteli, Gerhard Zenke, Nigel Graham Cooke, Rudolf Duthaler, Gebhard Thoma +7 more 2013-04-30
7943627 2,4-diaminopyrimidine derivatives Rolf Baenteli, Gerhard Zenke, Nigel Graham Cooke, Rudolf Duthaler, Gebhard Thoma +7 more 2011-05-17